The strategic research programme in the area of biotechnology applied to healthcare that was presented at the Institute for Bioengineering of Catalonia (IBEC), appears in the media by investing 32 million more in biotechnology.
Only by taking an integrated approach to tools for diagnosis, prognosis and advanced therapies will we be able to tackle the major challenges we face in healthcare, such as cancer, degenerative diseases and infectious diseases.
Josep Samitier, IBEC director and Scientific Coordinator of the Complementary Plan for Biotechnology Applied to Healthcare
This plan seeks to promote personalized medicine and the development of advanced therapies through science and innovation through the so-called Complementary Plans of the Recovery and Resilience Mechanism.
The event, hosted by Nuria Montserrat, IBEC’s Deputy Director of Clinical Translation and national coordinator of the biobanks and biomodels platform and that was attended by the Minister for Science and Innovation, Diana Morant, Catalonia’s Minister for Research and Universities, Gemma Geis, IBEC director and scientific coordinator of the complementary healthcare plan, Josep Samitier, and representatives of the other autonomous regions.
You can read the impact in the media here:
